TRANSACTIONS Despite being "the new kid on the block", our team has been off to a blazing start across the M&A and Capital Markets landscape FIND OUT MORE David Rosenberg 7/17/25 David Rosenberg 7/17/25 $70,000,000 Follow-On OfferingSole Book-Runner Read More David Rosenberg 7/16/25 David Rosenberg 7/16/25 $10,200,000 Follow-On OfferingSole Book-Runner Read More David Rosenberg 7/14/25 David Rosenberg 7/14/25 Merger transaction with HyperLiquid Fairness Opinion Read More David Rosenberg 7/11/25 David Rosenberg 7/11/25 $4,800,000 Follow-On OfferingSole Book-Runner Read More David Rosenberg 7/11/25 David Rosenberg 7/11/25 $9,200,000 Follow-On OfferingSole Book-Runner Read More David Rosenberg 7/10/25 David Rosenberg 7/10/25 $50,000,000 Series B Term PreferredJoint Book-Runner Read More David Rosenberg 6/30/25 David Rosenberg 6/30/25 Merger transaction with OrthoCellix Fairness Opinion Read More David Rosenberg 6/17/25 David Rosenberg 6/17/25 Merger transaction with Crescent Biopharma M&A Advisor to GlycoMimetics Read More David Rosenberg 6/5/25 David Rosenberg 6/5/25 $200,000,000 ATM OfferingCo-Sales Agent Read More David Rosenberg 6/3/25 David Rosenberg 6/3/25 $10,000,000 ATM OfferingSole Placement Agent Read More David Rosenberg 5/27/25 David Rosenberg 5/27/25 $40,000,000 Term LoanSole Placement Agent Read More David Rosenberg 5/16/25 David Rosenberg 5/16/25 $75,000,000 Perpetual Preferred StockJoint Book-Runner Read More David Rosenberg 5/6/25 David Rosenberg 5/6/25 $100,000,000 ATM OfferingSole Placement Agent Read More David Rosenberg 4/14/25 David Rosenberg 4/14/25 $250,000,000 ATM OfferingPlacement Agent Read More David Rosenberg 4/14/25 David Rosenberg 4/14/25 $500,000,000 ATM OfferingPlacement Agent Read More David Rosenberg 3/19/25 David Rosenberg 3/19/25 $55,900,000 Sale of Private AssetsFinancial Advisor Read More David Rosenberg 3/4/25 David Rosenberg 3/4/25 $50,000,000 ATM OfferingJoint Placement Agent Read More David Rosenberg 2/27/25 David Rosenberg 2/27/25 $50,000,000 Preferred Stock OfferingCo-Manager Read More David Rosenberg 2/26/25 David Rosenberg 2/26/25 $30,000,000 Follow-On OfferingCo-Lead Manager Read More David Rosenberg 2/24/25 David Rosenberg 2/24/25 $185,000,000 Baby BondLead Book-Runner Read More Older Posts
David Rosenberg 7/17/25 David Rosenberg 7/17/25 $70,000,000 Follow-On OfferingSole Book-Runner Read More
David Rosenberg 7/16/25 David Rosenberg 7/16/25 $10,200,000 Follow-On OfferingSole Book-Runner Read More
David Rosenberg 7/14/25 David Rosenberg 7/14/25 Merger transaction with HyperLiquid Fairness Opinion Read More
David Rosenberg 7/11/25 David Rosenberg 7/11/25 $4,800,000 Follow-On OfferingSole Book-Runner Read More
David Rosenberg 7/11/25 David Rosenberg 7/11/25 $9,200,000 Follow-On OfferingSole Book-Runner Read More
David Rosenberg 7/10/25 David Rosenberg 7/10/25 $50,000,000 Series B Term PreferredJoint Book-Runner Read More
David Rosenberg 6/30/25 David Rosenberg 6/30/25 Merger transaction with OrthoCellix Fairness Opinion Read More
David Rosenberg 6/17/25 David Rosenberg 6/17/25 Merger transaction with Crescent Biopharma M&A Advisor to GlycoMimetics Read More
David Rosenberg 5/16/25 David Rosenberg 5/16/25 $75,000,000 Perpetual Preferred StockJoint Book-Runner Read More
David Rosenberg 5/6/25 David Rosenberg 5/6/25 $100,000,000 ATM OfferingSole Placement Agent Read More
David Rosenberg 3/19/25 David Rosenberg 3/19/25 $55,900,000 Sale of Private AssetsFinancial Advisor Read More
David Rosenberg 3/4/25 David Rosenberg 3/4/25 $50,000,000 ATM OfferingJoint Placement Agent Read More
David Rosenberg 2/27/25 David Rosenberg 2/27/25 $50,000,000 Preferred Stock OfferingCo-Manager Read More
David Rosenberg 2/26/25 David Rosenberg 2/26/25 $30,000,000 Follow-On OfferingCo-Lead Manager Read More